Skip to main content
Top
Published in: BMC Psychiatry 1/2021

Open Access 01-12-2021 | Mood Disorders | Research

Users’ perceptions about receiving personalized depression risk information: findings from a qualitative study

Authors: Heidi Eccles, Doaa Nadouri, Molly Nannarone, Bonnie Lashewicz, Norbert Schmitz, Scott B. Patten, Douglas G. Manuel, JianLi Wang

Published in: BMC Psychiatry | Issue 1/2021

Login to get access

Abstract

Objectives

To understand users’ perceptions about receiving their personalized depression risk score and to gain an understanding about how to improve the efficiency of risk communication from the user perspective.

Methods

A qualitative study embedded in a randomized controlled trial (RCT) on evaluating the impact of providing personalized depression risk information on psychological harms and benefits. The participants (20 males and 20 females) were randomly selected from the intervention arm of the RCT after the 12-month assessment. The qualitative interviews were conducted through telephone, audio recorded and transcribed verbatim. We conducted a content analysis to describe the content and contextual meaning of data collected from participants.

Results

The first theme explained the motivation for receiving a risk score. Most participants chose to receive their personalised depression risk score with the goal of improving their self-awareness. The results revealed three sub-themes surrounding perceptions and implication of receiving their risk score: positive, negative, and neutral. Most participants found that receiving their score was positive because it improved their awareness of their mental health, but some participants could see that some people would have negative feelings when getting the score causing them to be more likely to get depression. The final theme focussed on improvements including: the best delivery methods, having resources and strategies, and targeting younger people.

Conclusion

The most significant motivation for, and benefit of receiving one’s personalized depression risk score was improved awareness of one’s mental health. A comprehensive risk communication program may improve the uptake and maximize the impact on behavior changes and risk reduction.
Literature
4.
go back to reference Moreno-Kustner B, Motrico E, Bellón J, Gil-De-Gómez-Barragán M, Díaz-Barreiros M, Martínez-Cañavate M, et al. FC03-04 - the importance of measuring functional impairment with the composite international diagnostic interview in depression research. A PredictD-Spain study. Eur Psychiatr. 2010;25:190. https://doi.org/10.1016/s0924-9338(10)70190-5.CrossRef Moreno-Kustner B, Motrico E, Bellón J, Gil-De-Gómez-Barragán M, Díaz-Barreiros M, Martínez-Cañavate M, et al. FC03-04 - the importance of measuring functional impairment with the composite international diagnostic interview in depression research. A PredictD-Spain study. Eur Psychiatr. 2010;25:190. https://​doi.​org/​10.​1016/​s0924-9338(10)70190-5.CrossRef
21.
go back to reference Wang J, Eccles H, Nannarone M, Scmitz N, Patten S, Lashewicz B. Does providing personalized depression risk information lead to increased psychological distress and functional impairment? Results from a mixed-methods randomized controlled trial. Psychol Med. 2020:1–9. https://doi.org/10.1017/S0033291720003955. Wang J, Eccles H, Nannarone M, Scmitz N, Patten S, Lashewicz B. Does providing personalized depression risk information lead to increased psychological distress and functional impairment? Results from a mixed-methods randomized controlled trial. Psychol Med. 2020:1–9. https://​doi.​org/​10.​1017/​S003329172000395​5.
22.
go back to reference Wang JL, MacQueen G, Patten S, Manuel D, Lashewicz B, Schmitz N. A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: A research protocol. BMC Psychiatr. 2019;19(1):285. https://doi.org/10.1186/s12888-019-2270-2279.CrossRef Wang JL, MacQueen G, Patten S, Manuel D, Lashewicz B, Schmitz N. A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: A research protocol. BMC Psychiatr. 2019;19(1):285. https://​doi.​org/​10.​1186/​s12888-019-2270-2279.CrossRef
Metadata
Title
Users’ perceptions about receiving personalized depression risk information: findings from a qualitative study
Authors
Heidi Eccles
Doaa Nadouri
Molly Nannarone
Bonnie Lashewicz
Norbert Schmitz
Scott B. Patten
Douglas G. Manuel
JianLi Wang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2021
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-021-03590-8

Other articles of this Issue 1/2021

BMC Psychiatry 1/2021 Go to the issue